Heart Failure Society of America (HFSA) practice guidelines. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction--pharmacological approaches

J Card Fail. 1999 Dec;5(4):357-82.
No abstract available

Publication types

  • Guideline
  • Practice Guideline
  • Review

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Angiotensin Receptor Antagonists
  • Anticoagulants / therapeutic use
  • Cardiovascular Agents / classification
  • Cardiovascular Agents / therapeutic use*
  • Female
  • Heart Failure / drug therapy*
  • Heart Failure / physiopathology
  • Humans
  • Male
  • Mineralocorticoid Receptor Antagonists / therapeutic use
  • Platelet Aggregation Inhibitors / therapeutic use
  • Systole
  • United States
  • Ventricular Dysfunction, Left / drug therapy*
  • Ventricular Dysfunction, Left / physiopathology

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin Receptor Antagonists
  • Anticoagulants
  • Cardiovascular Agents
  • Mineralocorticoid Receptor Antagonists
  • Platelet Aggregation Inhibitors